Latest filing published 14 Apr 2025 for GSK plc, €866.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Dr Jesse Goodman: trading record in brief
Dr Jesse Goodman is a declared insider of GSK plc, with filings sourced from RNS (LSE). In total, 17 filings cover trades dated from 20 June 2023 to 11 April 2025.
Every open-market trade on record is a purchase: 8 purchases worth €84k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 9 share grants. Since January 2025: 1 purchase and no sales on the market.
The median purchase comes to €11k. On 8 out of 8 purchases, another insider of the same company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
Most recently, on 14 April 2025, the filings show a share grant worth €866 in GSK plc. The last purchase on record was published on 21 March 2025, which is 598 days ago. Between a trade and the moment it shows up on RNS (LSE), the median delay is 3 days. The regulation allows three business days to notify a trade (UK MAR). Source: insider filings from RNS (LSE). Past trades are no guide to future returns.
Companies and markets linked to Dr Jesse Goodman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 22 shares@ £34.13640.2% of flowNew York Stock Exchange (XNYS)ISIN US37733W2044RNS:5617047-5
- 6,842 shares@ £38.80578.3% of flowNew York Stock Exchange (XNYS)ISIN US37733W2044RNS:5593269-3
- 249 shares@ £39.27312.9% of flowNew York Stock Exchange (XNYS)ISIN US37733W2044RNS:5584787-7Canonical exit: 18 Jun 2025 (T+90)
- 18 shares@ £33.33330.2% of flowNew York Stock Exchange (XNYS)ISIN US37733W2044RNS:5498728-21
- 271 shares@ £33.80812.7% of flowNew York Stock Exchange (XNYS)ISIN US37733W2044RNS:5479029-7Canonical exit: 20 Mar 2025 (T+90)
- 14 shares@ £39.07140.2% of flowNew York Stock Exchange (XNYS)ISIN US37733W2044RNS:5388451-5
- 224 shares@ £41.01342.7% of flowNew York Stock Exchange (XNYS)ISIN US37733W2044RNS:5362280-6Canonical exit: 22 Dec 2024 (T+90)
- 12 shares@ £39.33330.1% of flowNew York Stock Exchange (XNYS)ISIN US37733W2044RNS:5266837-15
- 225 shares@ £40.76442.7% of flowNew York Stock Exchange (XNYS)ISIN US37733W2044RNS:5235239-6Canonical exit: 18 Sept 2024 (T+90)
- 9 shares@ £41.000.1% of flowNew York Stock Exchange (XNYS)ISIN US37733W2044RNS:5143847-29
- 219 shares@ £41.90412.6% of flowNew York Stock Exchange (XNYS)ISIN US37733W2044RNS:5116598-7Canonical exit: 18 Jun 2024 (T+90)
- 6 shares@ £40.16670.1% of flowNew York Stock Exchange (XNYS)ISIN US37733W2044RNS:5034561-28
- 227 shares@ £36.61672.4% of flowNew York Stock Exchange (XNYS)ISIN US37733W2044RNS:5012405-7Canonical exit: 19 Mar 2024 (T+90)
- 4 shares@ £37.000.0% of flowNew York Stock Exchange (XNYS)ISIN US37733W2044RNS:4939502-7
- 220 shares@ £38.02732.4% of flowNew York Stock Exchange (XNYS)ISIN US37733W2044RNS:4907954-6Canonical exit: 19 Dec 2023 (T+90)
- 2 shares@ £35.000.0% of flowNew York Stock Exchange (XNYS)ISIN US37733W2044RNS:4837969-22
- 240 shares@ £34.74172.4% of flowNew York Stock Exchange (XNYS)ISIN US37733W2044RNS:4813178-5Canonical exit: 18 Sept 2023 (T+90)
17 of 16 declarations
